Psychiatry / mental health clinical trials recruiting in Florida

113 recruiting psychiatry / mental health trials match in Florida. Showing 20.

• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderRecruiting

  Phase 3 · Alkermes, Inc. · Miami Lakes, Florida

• Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderRecruiting

  Phase 3 · Intra-Cellular Therapies, Inc. · Gainesville, Florida

• A Study to Evaluate the Effect of KarXT on Urological SafetyRecruiting

  Phase 4 · Bristol-Myers Squibb · Lauderhill, Florida

• A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional DysregulationRecruiting

  Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc. · New Orleans, Louisiana

• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderRecruiting

  Phase 2 · Syndeio Biosciences, Inc · Naples, Florida

• A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer SurvivorsRecruiting

  Phase 4 · Memorial Sloan Kettering Cancer Center · Miami, Florida

• A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)Recruiting

  Phase 2 · Alkermes, Inc. · Clermont, Florida

• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRecruiting

  Phase 4 · Axsome Therapeutics, Inc. · Brandon, Florida

• Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)Recruiting

  N/A · University of South Florida · Tampa, Florida

• A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruiting

  Phase 3 · Eli Lilly and Company · Hollywood, Florida

• A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)Recruiting

  Phase 3 · Bristol-Myers Squibb · Orlando, Florida

• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Recruiting

  Phase 3 · Definium Therapeutics US, Inc. · Maitland, Florida

• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderRecruiting

  Phase 2 · AbbVie · Gainesville, Florida

• A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderRecruiting

  Phase 2 · VistaGen Therapeutics, Inc. · Largo, Florida

• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Recruiting

  Phase 2 · Autobahn Therapeutics, Inc. · Brandon, Florida

• A Study of Brenipatide in Adult Participants With SchizophreniaRecruiting

  Phase 2 · Eli Lilly and Company · Cooper City, Florida

• A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Coral Springs, Florida

• Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHDRecruiting

  Phase 4 · Supernus Pharmaceuticals, Inc. · Coral Gables, Florida

• A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)Recruiting

  Phase 3 · Intra-Cellular Therapies, Inc. · Miami, Florida

• Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderRecruiting

  Phase 1 · BioXcel Therapeutics Inc · Hialeah, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.